However, the bioinformatic analysis of 374 LIHC patients from the TCGA database (Figure 1) indicated that SETD2 was upregulated in HCC and that high SETD2 expression was related to a poor prognosis. The gene discussed is SETD2; the disease is hepatocellular carcinoma.